35 Burst results for "Biontech"

Naomi Wolf Reveals SHOCKING Details of the COVID Vaccine

The Eric Metaxas Show

01:30 min | 2 d ago

Naomi Wolf Reveals SHOCKING Details of the COVID Vaccine

"Hey there folks talking to Naomi wolf. So Naomi, just to focus the point here, you're suggesting that the Chinese communists intended to harm and kill non Chinese through these vaccines. Yes or no? Well, I'm a reporter, so I don't jump ahead of the evidence, right? So what I'm telling you that I know is that these injections are now the IP has been a 100% transferred the SEC filing of 2021 since the IP of these injections of BioNTech Pfizer are transferred to China. It doesn't say a Chinese individual. It doesn't say a Chinese company. It's his two China, the country of China. So now in 2022, if you get a Pfizer injection, you're getting an injection that is overseen manufactured and distributed under the ownership of China, which is our existential adversary in a totalitarian regime that kills its own people, harvests organs from its own people. So that I know. And I also know that there are catastrophic levels of harm in the Pfizer documents, particularly and I didn't even finish the evidence, but I can go back to it. Please sterilizing the next generation.

Naomi Wolf China Pfizer Naomi SEC
EU regulator clears Pfizer-BioNTech's tweaked COVID booster

AP News Radio

00:42 sec | 2 weeks ago

EU regulator clears Pfizer-BioNTech's tweaked COVID booster

"European Union health officials have cleared the way for an updated Pfizer BioNTech COVID booster I Norman hall the European medicines agency is recommended the authorization of a tweaked booster dose of Pfizer's BioNTech coronavirus vaccine The updated version will include protection against two of the latest versions of omicron as countries look to bolster their immunization programs ahead of winter the combination booster will target both the original COVID-19 virus as well as the sub variants BA four and BA 5 and should trigger a safe effective immune response According to the World Health Organization the BA 5 version is a responsible for most of the COVID-19 spreading globally I Norman hall

Norman Hall Pfizer European Medicines Agency European Union World Health Organization
"biontech" Discussed on AP News

AP News

02:15 min | Last month

"biontech" Discussed on AP News

"As an AP news minute, Moderna is suing Pfizer and its COVID vaccine partner BioNTech accusing its competitors of copying their mRNA technology. The company has filed patent infringement lawsuits, but is not seeking to remove the vaccine from the market while the pandemic continues. Pfizer says its vaccine was developed on proprietary technology and will defend the suit, the mRNA vaccines work by injecting a genetic code for the spike protein that coats the surface of the coronavirus, that code, the mRNA is encased in a little ball of fat and instructs the body's cells to make some harmless spike copies that train the immune system to recognize the real virus. Meanwhile, Pfizer and BioNTech have asked European Union drug regulators to authorize their updated coronavirus booster that includes the most recent omicron sub variants. It's a combination COVID vaccine that targets the original virus NBA four NBA 5, which are now causing the vast majority of infections globally. Back here in the U.S., the New Mexico Supreme Court is upholding a lower court decision dismissing a lawsuit by prison inmates in 2020, trying to get released because of the pandemic. They claimed the state's COVID response in prison violated their constitutional rights, and the federal government is suspending 26 flights by Chinese airlines flying from the U.S. to China in a dispute over anti virus controls after Beijing suspended flights by American carriers. The Department of Transportation says China violated an agreement and treated airlines unfairly under a system that requires them to suspend flights if passengers test positive for COVID. Julie Walker, AP news, a car once owned by Princess Diana sells at auction for just under $764,000, and you may not believe what it is. 550,000 pounds on the four escort I've never said that before. In the end, Silverstone auctions, Jonathan humbert sold Princess Diana's 1985 black Ford escort RS turbo S one with just under 25,000 miles on it for just under $764,000,

BioNTech Pfizer Moderna New Mexico Supreme Court NBA COVID European Union U.S. Julie Walker China federal government Department of Transportation Beijing Princess Diana Jonathan humbert Ford
"biontech" Discussed on Bloomberg Radio New York

Bloomberg Radio New York

02:07 min | Last month

"biontech" Discussed on Bloomberg Radio New York

"The Dow Jones Industrial Average fell more than 1000 points Friday. The S&P was down one 41, the NASDAQ lost almost 500 points. I'm Brad Siegel. Wildfires in California can be deadly, especially for one group of people. Julie Ryan has more. The McKinney fire claimed the lives of four klamath river residents. They were 82, 79, 76 and 73 years old. The campfire in 2018 had 85 fatalities with a majority of them over 65 years old. Experts say they're seeing more fire related fatalities in older people because they're more likely to live in rural areas where living expenses are lower, but it makes escaping a fire harder. Senior citizens are also prone to chronic illnesses and disabilities that limit mobility. Others choose to stay in their homes and hope for the best. I'm Julie Ryan. NBC is reportedly looking at chomping its prime time TV hours as a cost cutting strategy. According to The Wall Street Journal, which cited people familiar with the plan, the peacock network would eliminate the 10 p.m. hour each night, giving those 7 total hours per week to local TV stations. The paper says the change could happen in fall 2023 at the earliest. I'm Phil hutt. Japan's government says it's spending nearly $2 million on a state funeral for the late premier Shinzo Abe. The government of prime minister kishida made that announcement and said Abe's funeral will be paid for solely with state funds. The latest opinion Poland Japan shows over half of those who responded were against a state funeral for Japan's longest serving premier, who was assassinated last month. The state funeral for Abe will be held September 27th in Tokyo. Moderna is suing Pfizer and BioNTech over alleged patent infringement, specifically the lawsuit involves the two companies, making their COVID vaccine by using Moderna's technology, Pfizer, and its German partner are accused of copying it after Moderna filed patents for mRNA technology between 2010 and 2016, Pfizer and Moderna have produced two of the vaccines people around the world have used to

Julie Ryan Brad Siegel klamath river Phil hutt McKinney prime minister kishida Japan Moderna Abe California Shinzo Abe NBC The Wall Street Journal BioNTech Pfizer Poland Tokyo
"biontech" Discussed on Bloomberg Radio New York

Bloomberg Radio New York

01:39 min | Last month

"biontech" Discussed on Bloomberg Radio New York

"Paul. New details are coming to light with the release of a heavily redacted affidavit used to justify the FBI's search of Mar-a-Lago. Loyal a law professor Jessica Levinson tells Bloomberg much of the document is blacked out. The front half of the affidavit where we have more information about the statutes and we have more information about the negotiations between the national archives and the Department of Justice and former president Trump and his attorneys, that's all open, but then everything else leaning into really the maybe more juicy quote unquote parts about probable cause and why it existed. That is all blacked out and I would say for good reason. Loyola law professor Jessica Levinson spoke with David Westin on Bloomberg balance of power, the Justice Department found a 184 classified documents and 14 of 15 return boxes. Moderna is suing its biggest rivals in the COVID-19 vaccine market. The drug maker has filed patent infringement lawsuits against Pfizer and BioNTech in the U.S. and Germany, accusing the two of violating patents protecting key elements of Moderna's messenger RNA technology. Moderna is not asking the courts to pull the Pfizer BioNTech COVID vaccine from the market or to block future sales. The company is seeking damages for the period starting march 8th of this year. LastPass, a password manager used by more than 33 million people around the world says a hacker recently broke into its systems and stole source code and proprietary information. Global news 24 hours a day on air and on Bloomberg quicktake powered by more than 2700

Jessica Levinson Moderna Justice Department David Westin Bloomberg national archives FBI BioNTech Trump Pfizer Paul Loyola LastPass Germany U.S.
"biontech" Discussed on WTOP

WTOP

02:30 min | Last month

"biontech" Discussed on WTOP

"Morning, I'm Gigi Barnett. And I'm John Aaron Acacia James is our producer. The top stories we're following for you today, new details are expected about why the FBI search former president Trump's estate for hundreds of classified documents allegedly taken from The White House. A judge has ordered that a version of the court documents used by the government justifying the search should be released. The Justice Department has until noon today to release a redacted version of the affidavit to the public. Now, there could be heavy redactions. This is an ongoing probe. But it could still offer new insight into why FBI agents arrived at former president Trump's home, search warrant in hand. And that CBS News chief elections and campaign correspondent Robert Costa. Moderna is now suing Pfizer alleging infringement of its patent on the technology behind the COVID-19 vaccine. CBS News reporter Alex tin has details. Moderna says it is suing Pfizer and BioNTech accusing the companies of infringing on their patents in creating their blockbuster COVID-19 vaccine, and then failing to get a license to use those techniques for their shots. Moderna says it won't be seeking damages for sales in low income countries or for where the United States government would have to foot the bill. A spokesperson for Pfizer declined to comment saying the company had yet to be served the suit. Patton lawsuits are common in the BioTech industry, they typically play out over years and often wind up in federal appeals courts. Today is women's equality day, which marks a date that the Nineteenth Amendment was certified at recognizes the right of women to vote. The White House will mark the occasion by meeting with state and local leaders to discuss ways to safeguard access to abortions, senior White House officials will meet with leaders from Maryland and four other states amid a flurry of legal challenges to the administration's efforts to protect reproductive rights. A former fairfax county school counselor who remained on the job after an arrest on charges of soliciting prostitution from a minor has been arrested again. This time he's accused of lying on Virginia's state sex offender registry by saying he was unemployed. Last night, the county school's chief discussed the scandal with parents. It's safe to say we've lost trust with many families as a result of this incident. FCP has superintendent Michelle Reed met with about two dozen parents at a community meeting at Glasgow middle school. They wanted answers about how former counselor Darren Thornton remained employed despite his conviction as a sex offender in another county. Stacey Ali Abraham's 8th grader used to meet with Thornton. I'd like to

Moderna Gigi Barnett John Aaron Acacia James Pfizer Trump CBS News Robert Costa FBI COVID Alex tin BioNTech White House Justice Department United States government Patton government fairfax county Maryland Michelle Reed Glasgow middle school
Moderna sues Pfizer over patents behind COVID-19 vaccine

AP News Radio

00:43 sec | Last month

Moderna sues Pfizer over patents behind COVID-19 vaccine

"I'm Mike Gracia reporting Moderna Sue's Pfizer over patents behind the COVID-19 vaccine Moderna is suing Pfizer and German drug maker mayon tech accusing its two main competitors of copying Moderna's technology to make their own COVID-19 vaccine Moderna says Pfizer and BioNTech's vaccine known as community infringes on patents Moderna filed years ago for the technology behind its vaccine known as spike vax Moderna and Pfizer's two shot vaccines both use mRNA technology to help patients fight the coronavirus Moderna filed patent infringement lawsuits in both U.S. federal court and a German court a Pfizer spokeswoman declined to comment I'm Mike Gracia

Moderna Pfizer Mike Gracia Moderna Sue Mayon Tech Biontech U.S. Federal Court German Court
"biontech" Discussed on TIME's Top Stories

TIME's Top Stories

03:30 min | Last month

"biontech" Discussed on TIME's Top Stories

"Pfizer BioNTech submits the first omicron COVID-19 booster for FDA authorization by Alice park. All COVID-19 vaccines that are used in the U.S. target the same original strain of SARS CoV-2. But boosters designed to protect against the latest omicron sub variants could be coming soon. On August 22nd, Pfizer BioNTech submitted a request to the U.S. Food and Drug Administration to authorize its omicron specific vaccine. The shot targets be a four and BA 5, which now account for nearly all new infections in the U.S., and an announcement Pfizer BioNTech requested emergency use authorization for a booster dose of the vaccine which contains a combination of the genetic material mRNA from the original virus circulating when the vaccine was initially approved in August 2021, and mRNA from the newer BA four and BA 5 sub variants. The vaccine is intended for any one 12 years or older. The companies have been studying the BA four and BA 5 vaccine in animal models and submitted that data to the FDA for review. Those studies showed the vaccine was safe and produced a strong neutralizing antibody response against omicron BA one, BA two, and BA four BA 5. The companies said in a statement. Pfizer BioNTech says it has scaled up production of the BA four BA 5 vaccine, and is ready to begin shipping immediately if the FDA authorizes the shot. The FDA has not indicated a timetable for if and when that might happen, but given that the agency requested that vaccine makers develop a BA four BA 5 booster in time to protect people in the fall and winter months when respiratory viruses like SARS CoV-2 circulate more quickly, the agency will likely act as quickly as possible. If the agency authorizes the booster, The White House's COVID-19 response coordinator, doctor Ashish jha predicted on August 16th, that the shot could be available by early to mid September. Data regarding the safety and efficacy of the omicron specific vaccine in people are not available yet, those studies in humans are expected to start later in August, the company's sad. In addition to the animal data, the request is based on limited human data, Pfizer BioNTech generated with a related vaccine, which targeted another version of the omicron variant, BA one, an FDA panel of independent experts reviewed that data in June, and decided not to consider it for authorization, and asked the companies to develop a vaccine targeting the BA four and BA 5 sub variants and stad. Other vaccine makers are also developing omicron specific vaccines, and likely won't be far behind in requesting FDA authorization. Moderna, which makes the other mRNA COVID-19 vaccine approved by the FDA, released promising data in June showing its vaccine, which also targeted the BA one sub variant, produced higher levels of virus fighting antibodies against omicron and people compared to the original vaccine. At the FDA's request, Moderna is also developing a BA four BA 5 specific version of its omicron vaccine..

Pfizer FDA Alice park SARS Pfizer BioNTech U.S. COVID Ashish jha White House Moderna
CDC urges Pfizer booster for children ages 5 to 11

AP News Radio

00:48 sec | 4 months ago

CDC urges Pfizer booster for children ages 5 to 11

"While U.S. parents still await approval of a COVID-19 vaccine for children under 5 regulators are giving the go ahead on booster shots for elementary school aged kids U.S. health advisers are urging a booster dose of Pfizer's COVID-19 vaccine for kids ages 5 to 11 CDC epidemiologist doctor Sarah Oliver presented data on Thursday before a CDC advisory panel voted to approve the boosters A single Pfizer BioNTech COVID-19 vaccine booster dose is recommended for persons ages 5 through 11 years at least 5 months after the primary series under the FDA's emergency use authorization The Centers for Disease Control and Prevention quickly signed off on the advice the decision opens a third COVID-19 shot to healthy elementary school kids just like what is already recommended for everyone 12 and older I'm Jennifer King

Centers For Disease Control An Sarah Oliver Pfizer U.S. FDA Jennifer King
BioNTech plans modular vaccine factories in Africa

AP News Radio

00:46 sec | 8 months ago

BioNTech plans modular vaccine factories in Africa

"German vaccine maker by on tech has unveiled plans to establish manufacturing facilities in Africa that would boost the availability of much needed medicines on the continent the modular design of the coal facility consists of shipping containers fitted with the equipment necessary to make the company's M. RNA based vaccines from start to finish save the final step the filling doses in the bottles the first facility will be shipped to Senegal Rwanda in the second half of this year by on tech aims to stop production of up to fifty million doses of vaccines a year that within twelve months pending approval from local regulators by on tech developed the first widely approved shot against Kevin nineteen together with FISA I'm Charles de Ledesma

Africa Senegal Rwanda Kevin Nineteen Charles De Ledesma
"biontech" Discussed on TIME's Top Stories

TIME's Top Stories

02:34 min | 8 months ago

"biontech" Discussed on TIME's Top Stories

"Brought to you by Shopify, start selling today. Pfizer and BioNTech start studies of an omicron specific vaccine by Alice park Pfizer and BioNTech announced today that they have started testing an omicron specific COVID-19 vaccine in healthy adults, while data show that the current vaccine made by the companies and approved by the U.S. Food and Drug Administration continues to protect against severe disease, the vaccine is less effective at preventing infection with the virus. Studies also show that the level of immune cells generated by the vaccine wanes over time, which led the FDA to authorize a booster dose. The quick dominance of the omicron variant made clear the need to increase the protection provided by the existing vaccine and the shots mRNA technology allowed scientists to modify the genetic base of the vaccine to reflect the omicron variant and only about 6 weeks. The new study will include more than 1400 people divided into three groups. One group includes people who have been vaccinated with two doses of the current vaccine and will receive one or two doses of the new omicron vaccine. Another group includes those who have been vaccinated and boosted with the Pfizer BioNTech vaccine and will receive a fourth dose of the existing vaccine or a dose of the omicron shot. The final group includes unvaccinated people who will get three doses of the omicron vaccine. The data will allow researchers to compare infections and symptoms among people who are currently vaccinated and who get one dose or two doses of the omicron shot to those who have been boosted with the current vaccine and receive a dose of the uma cron vaccine. The data will help scientists and public health experts to learn more about how beneficial variant specific vaccines might be, and whether they will be necessary going forward. Woohoo. 300 Shopify sales. How? Where are you selling 300 pairs of tap shoes, mom? With our Shopify store, we can connect and sell everywhere. Facebook, Instagram, TikTok, you name it. You did all that. Yes. Shopify makes it easy to integrate into marketplaces and social channels, reaching customers where they're already shopping. The all in one commerce platform designed to take you from first sale to full scale. In 2022, this is possibility. Powered by Shopify, go to Shopify dot com slash brief for a free 14 day trial, Shopify dot com slash brief..

BioNTech Alice park Pfizer Pfizer U.S. Food and Drug Administrat Shopify store Shopify Instagram Facebook
"biontech" Discussed on WTOP

WTOP

03:03 min | 8 months ago

"biontech" Discussed on WTOP

"Row house collapse I'm Megan clarity Down day on Wall Street Good morning It's 3 o'clock This is CBS News on the hour Your home for original reporting I'm Monica rix in New York Russia's not showing any signs of backing down at the border in Ukraine prompting fears around the world that the Kremlin could start a war CBS Skyler Henry is in Washington We have a sacred obligation article 5 obligation to our NATO allies The White House hopes the threat of severe economic sanctions will be enough to deter hostilities You gotta make it clear that there's no reason for anyone any member of NATO to worry whether or not we would NATO would come to their defense Russia denies its planning to invade Ukraine the Kremlin has also accused the U.S. of building up tensions by evacuating diplomats and placing military forces on standby All eyes are on the Federal Reserve today as it considers raising interest rates CBS is just lessenger reports Today the Federal Reserve concludes a two day policy meeting where it's not expected to raise interest rates However the central bankers are likely to lay the groundwork for future rate increases starting as early as the next meeting in March COVID isn't ending anytime soon scientists are now monitoring a new version of the highly contagious omicron variant CBS is Natalie Brandt has the latest Little is known about the BA two strain which has been detected in Europe Asia and multiple U.S. states The conditions are ideal for more variants to emerge Drug maker Pfizer and its partner BioNTech announced the start of clinical trials of an omicron specific vaccine initial data is expected by June Police in San Francisco say attacks on Asian Americans and Pacific islanders have gone up dramatically in the last year Dozens of hate crimes have been reported in 2021 compared to just 9 in 2020 But officials say stats don't show the whole picture since most attacks aren't charged as hate crimes Homeland Security says extremist groups in the U.S. could be targeting the power grid CBS Catherine heritage Homeland Security noted several indicators including online chatter an alleged plots by far right anti government groups targeting a substation in Las Vegas as well as power networks in the southeast While the report does not suggest an imminent threat the Homeland Security secretary has warned lone wolf actors and small bands of extremists are among the greatest domestic threat Officials have changed their minds about fans wearing punk Shui t-shirts at the Australian open as long as they don't gather in big groups The tennis star has been noticeably absent from events and tournaments months after accusing a Chinese Communist Party leader of sexual assault Officials at the open ban the shirts initially claiming they were political statements This is CBS News I really messed this one up What's wrong Valentine's Day I procrastinated and now I'm stuck It's easy dominion jewelers I thought they only had custom jewelry.

NATO CBS Monica rix Skyler Henry Ukraine Russia Federal Reserve Natalie Brandt CBS News BioNTech June Police U.S. Megan Kremlin Homeland Security White House Washington New York Pfizer Asia
"biontech" Discussed on TIME's Top Stories

TIME's Top Stories

04:18 min | 10 months ago

"biontech" Discussed on TIME's Top Stories

"Brought to you by audible. Pfizer BioNTech booster protects against oma cron by Alice park. Pfizer BioNTech today reported the first early results of studies examining how well their vaccine protects against the fast spreading omicron variant. The company's say that adding a booster to the two dose vaccine regimen, neutralizes the omicron variant in lab studies, and a press release, the companies noted that while two doses of their COVID-19 vaccine show decreased protection against omikron, a booster dose significantly raises that protection. Blood samples from people vaccinated with a booster showed 25 fold higher levels of neutralizing antibodies against a Macron compared to blood serum from people immunized with just two doses. Essentially, the booster brought levels of these virus fighting antibodies back to those seen after two doses against the original virus strain. More durable immune responses involving T cells were also higher against ome after a booster dose. The findings, while preliminary, are encouraging for several reasons. First, they suggest that the current vaccine can continue to protect against the new variant. Researchers still don't know how dangerous, they continue to study how transmissible they variant in as well as whether it causes more severe disease or evades the protection provided by vaccines. Results of those studies are expected soon until then these findings sent that the existing vaccines can still thwart OM, as long as people receive a booster dose. The early results showed that two doses alone aren't sufficient. After two doses, the immune system generated significantly lower levels of antibodies that could neutralize a Macron. The data very clearly indicate the value of a third dose BioNTech CEO and cofounder Uber shaheen said during a briefing discussing the results. With the data now coming on the omicron variant, it is very clear that our vaccine for the omicron variant should be a three dose vaccine. The best strategy now to ensure protection would be to get a booster shot. Thereby improving levels of antibodies and improving levels of T cells, which are correlated with better protection against the currently circulating delta variant, and which we believe will also translate to better protection against the omicron variant. The findings do come with caveats. The studies were conducted not with live samples of the omicron variant, but with a lab made version of the virus, while it contained the same mutations, it's still a proxy for the actual variant virus. Shaheen said, researchers plan to conduct the same studies with live omicron samples in the coming weeks. While it's not clear exactly how the current vaccines continue to protect against new variants like oh Macron, immunologists say that the quality of antibodies generated against viruses continues to evolve and improve with each exposure or vaccine dose. That means that doses targeted against an earlier version of the virus could continue to provide protection against newer variants as well. Still, Pfizer and BioNTech, as well as other vaccine makers are developing a new vaccine designed to specifically target the omicron variant, the mRNA technology behind Pfizer BioNTech's shot is flexible enough that scientists expect to have the new vaccine created in about 6 weeks and tested a few months after that. By on tech expects the first batches of an omicron vaccine will be available by March, if it's needed, and authorized by regulators. The production process itself will stay the same. Chief operating officer at BioNTech said at the briefing about manufacturing a potential omicron vaccine. The only thing that will change is the blueprint of the new variant, apart from that, all the production steps, the mRNA, the lipid formulation, the fill and finish, will be exactly the same. With audible,.

Pfizer Alice park Uber shaheen BioNTech Shaheen
"biontech" Discussed on 77WABC Radio

77WABC Radio

02:53 min | 10 months ago

"biontech" Discussed on 77WABC Radio

"7 cents a gallon contending to fall We're making progress We're going to keep at it to ensure the American people are paying their fair share for gas U.S. troops in Ukraine off the table President Biden said he would not deploy U.S. troops to deter a possible Russian invasion The idea of the United States is going to unilaterally use force to confront Russia invading Ukraine is not on the cards right now Pfizer and BioNTech says a shot of their COVID-19 booster neutralizes the omicron variant at least partially this coming as a South African lab also released results on how the Pfizer vaccine fared against showing about a 40 fold reduction in vaccine induced antibodies Pfizer chief scientific officer Michael dulcet talked about it on CNN If you get your third booze it's rice 25 fold very dramatic So yes you know where you could say to be protected of omikron you really need a three dose series of vaccination And that's how we should look at it right now The three dose areas is what you need The partner said they're confident they will have an amateur and specific version of the vaccine ready For delivery by March of 2022 A New York Supreme Court judge granting a hearing Tuesday to challenge to mayor de Blasio's vaccine mandate the judge setting a hearing date of December 14th for arguments as to whether a temporary restraining order blocking de Blasio's order should be issued Protesters gathered outside of the mayor's home last night to voice their concerns about the mandate So they don't care about the 70,000 black people in this country in New York City that have gone I'm fascinated and two is that they don't have a job Then there is office has until December 13th the reply de Blasio was continuously defended his position I don't think anyone should be surprised about what we're seeing with the amaron variant with the extraordinary growth of cases that we're experiencing in this city and all over this country Look at a country like Germany right now shutdowns restrictions We can not let that happen So we had to take decisive action The mandate says that all New York City workers including members of the NYPD and FDNY be vaccinated against COVID-19 As we mentioned earlier The White House appears to be taking a wait and see approach to a potential invasion of Ukraine by Moscow this after President Biden and Russian president Vladimir Putin spoke for two hours Tuesday morning National security adviser Jake Sullivan we still do not believe the president Putin has made a decision what President Biden did today was lay out very clearly.

de Blasio Pfizer President Biden BioNTech Ukraine United States Michael dulcet New York Supreme Court Russia CNN New York City COVID FDNY NYPD Germany White House Jake Sullivan Vladimir Putin Moscow
"biontech" Discussed on TIME's Top Stories

TIME's Top Stories

03:57 min | 1 year ago

"biontech" Discussed on TIME's Top Stories

"Card. Get the card that's built for business. By American Express a new study makes the case for mixing and matching the Pfizer BioNTech Moderna and J&J vaccine doses by Alice park. As soon as health officials made it clear that the world would need a booster dose of the COVID-19 vaccine, they needed to know if people could mix doses of vaccines made by different manufacturers. In the first study to provide results on such cross dosing, researchers say that it's safe for people who received one of the three vaccines available in the U.S. to get a booster dose of another, and that they found early evidence that certain combinations might generate stronger immune responses than others. The study was published on a preprint server and not yet peer reviewed and came on the same day that the Food and Drug Administration convened a panel of outside experts to review modernist request to authorize a booster shot. The FDA and Centers for Disease Control have issued an emergency use authorization for Pfizer BioNTech booster, but is currently reviewing data on the safety and efficacy of booster from Moderna and J&J. For the mix and match study, the researchers studied 458 people who were originally immunized with Pfizer BioNTech Moderna or Johnson & Johnson, Janssen vaccines, and then randomly assigned to get a booster dose of one of the three about four to 6 months later. It wasn't designed to directly compare immune responses of one booster to another, but rather to give researchers a broad sense of whether overall the antibody responses produced were similar across all three boosters, for example to see whether people who initially got Pfizer BioNTech's vaccine produced similar immune responses after getting an additional dose of a Pfizer BioNTech Moderna or JNJ's shot. In general, people who received a booster of a vaccine that was different from the one they originally received saw antibody increases that were similar to or higher than in those who had received another dose of the same vaccine of their initial shots. There were small differences, however, people who received the single JNJ vaccine experienced higher jumps and levels neutralizing antibodies after getting a booster dose of the Pfizer BioNTech or Moderna vaccines compared to another dose of the JNJ vaccine, 50 fold for the former two versus 5 fold for the latter. It's not clear why, but it could be related to the fact that J&J's vaccine relies on a different technology than the ones made by Pfizer BioNTech and Moderna. The J&J shot uses an adenovirus vector to deliver viral genes to the immune system, which then recognizes them as foreign and mounts an attack, while Pfizer BioNTech and Moderna's vaccines utilize a new technology of delivering the mRNA form of SARS CoV-2's genetic material directly, and there is some early evidence that the difference technology may be able to elicit different types of immunity, some preliminary data suggests, for example, that J's vaccine may be more effective and quickly boosting T cell based responses that might be more durable and able to recognize new variants than the more heavily antibody based responses Moderna and Pfizer BioNTech generate initially. The FDA will be considering such data as it evaluates booster shots from Moderna and J&J Jansen on October 14th in October 15th. The findings are encouraging because they suggest that it's safe for providers to mix and match doses when it comes to boosters. Public health experts have advocated that every one who has spent immunized against COVID-19 cat a booster shot to combat waning protection from the vaccines in the face of the faster spreading delta variant, and the ability to get any of the three vaccines will ensure that more people will get.

Pfizer Moderna Alice park Food and Drug Administration JNJ J American Express Janssen Centers for Disease Control U.S. SARS COVID
Mike and Caller Angelo Discuss Why COVID Has Been so Politicized by the Left

Mike Gallagher Podcast

00:58 sec | 1 year ago

Mike and Caller Angelo Discuss Why COVID Has Been so Politicized by the Left

"G let's see if you can give me a theory as to why the left has politicized COVID so much Angelo is in Queens, New York. Hey Angelo, how are you happy Friday? Hey, how you doing, happy Friday? Well, I guess it's just all political, maybe they want to just keep people out of the voting boots. They want mail in voting because I have written I'm a victim and Merck is making a pill. The only difference is it's going to cost $750 instead of $4. That's what that has a lot to do with it. Ivermectin is very inexpensive, and that has a huge, huge aspect of this, I think. It's a cheap inexpensive drug, big pharma doesn't profit from it like they do. I mean, do you know how much money Pfizer and BioNTech and all of what the Moderna vaccine and Johnson & Johnson? You know how much money they're making? Holy

Angelo Queens Merck New York Biontech Pharma Pfizer Johnson & Johnson
 Pfizer-BioNTech ask EU agency to OK vaccine for kids 5-11

AP News Radio

00:30 sec | 1 year ago

Pfizer-BioNTech ask EU agency to OK vaccine for kids 5-11

"As millions of Americans get Pfizer's covert nineteen vaccine booster shots FDA advisers say some people who received the Doris vaccine should also get extra protection we do have a unanimous nineteen out of nineteen yeah both the advisory panel has endorsed a half dose booster after bitterness Dr Jacqueline Miller outlined data showing the vaccine's protection wanes over time eight thirty six point four percent decrease in the incidence of cases in

Pfizer Dr Jacqueline Miller FDA
Pfizer, Biontech Say Vaccine Is Safe for Young Children

NPR News Now

00:10 sec | 1 year ago

Pfizer, Biontech Say Vaccine Is Safe for Young Children

"Says. It's data show that it's cove in nineteen vaccine is safe and effective for children aged five to eleven. It's asking the food and drug administration for review last

Food And Drug Administration
"biontech" Discussed on KCRW

KCRW

02:09 min | 1 year ago

"biontech" Discussed on KCRW

"I'm Matt Gillum. The Pfizer Biontech shots have gotten the complete sign off from the FDA, the first covid vaccine in the nation to get full approval. That makes it easier for employers and schools to implement vaccine mandates. And it may also convinced some vaccine hesitant people to roll up their sleeves. Filippo Sarno is an executive administrator at Keck Medicine of USC, and he's been working with people in this vaccine Hesitant Group of Sarno told kcrw's press play. He's hopeful the news. That designation could change some minds. I think the information is out there. I think the axis is plentiful. And I do think. Finally, as more employers moved to the mandates, folks will be faced with a tough choice, whether they want to continue to be employed or or Or not, if they have such a strong belief that they don't want the vaccine. Approval comes after Pfizer showed the federal agency that their vaccine is more than 90% effective at preventing covid. It still remains under emergency youth authorization for people between the ages of 12 and 16 for now. This is KCRW. KCRW sponsors include Netflix, presenting the Queen's gambit now nominated for 18 Emmy Awards, including outstanding Limited series, lead actress and Taylor Joy and outstanding writing and directing Scott Prank. 43 at KCRW Matt Dillon with you for Morning edition just ahead of the program. We take a look at the origins of the coronavirus. Scientists are sort of base have divided themselves into two camps. One believe it believes it likely came from nature. The others think it may have leaked from a lab in China. The government is supposedly issuing a report that is due any day. Now we'll take a look at what might be in it coming up. You're listening to KCRW. I'm Larry Peril Next time on all things considered why some people who get covid are plagued with symptoms for many months after becoming infected also how fires can generate their own weather like tornadoes and what it means for folks on the ground and you'll hear from a former U. N diplomat on the situation in Afghanistan, plus local news, weather and traffic to it's all things considered from NPR and KCRW..

Matt Gillum Filippo Sarno Larry Peril Matt Dillon Afghanistan Taylor Joy Netflix China Scott Prank Pfizer 16 Keck Medicine FDA KCRW more than 90% NPR 12 two camps One first covid vaccine
"biontech" Discussed on Here & Now

Here & Now

05:53 min | 1 year ago

"biontech" Discussed on Here & Now

"Heidi gardens is an affordable housing complex with more than one hundred units in mckeesport about sixteen miles from pittsburgh. It might seem like a normal summer here. Kids are playing outside. Neighbors are talking but there are problems inside at high few for years tentative. Been complaining about all kinds of issues. i have. He'd all this winter. We had bad rodent problems here and then when this lincoln head of columbia comfort at ease when you come home. You're not supposed to sleep with one eye open. You're not supposed to sleep and discomfort. Because you don't know what's going on with your. I'm pretty much here right now. Because i'm still looking for somewhere else to go. This is the only have lay my head down those are attendants barbara brown. Dacia hooper and radia. Hell they say that. The growing list of complaints push them to organize so in may. Some residents voted to form attendant union with the help of a lawyer from the community justice project which provides free legal assistance across pennsylvania. The president of the tenant union tanya brown has lived here for nine years. She feels mistreated by the complexes management. Nice heat and stuff like that and everything proper about the tenets. It's unfair it's unfair. Babies in is building and stuff and everything. I got great grand baby. I got grandsons to somerset at him. Common stop bundled up call. Many residents say they'd like to move but they don't think they could easily find another place to live that's affordable other say they'll stay despite the conditions because of the close bonds. They have with their neighbors or other relatives. Who live there. High view is considered project based section eight. That means the apartments are privately owned but the landlord receives a federal subsidy to supplement. The rent tenants pay. Many tenants are either disabled or work in low wage. Jobs residents say conditions. There have been getting worse since the new owner came in a few years ago and they were shocked when we told them who the owner is property. Records list hive us owner as the generically named mckeesport urban holdings to llc that company has been controlled by pnc bank since twenty eighteen which led resident dacia hooper to ask in z. Y. nothing being done. The pittsburgh-based bank is one of the biggest in the country with more than four hundred and sixty billion dollars in assets according to the federal reserve board. Pnc has a unit that buys affordable properties which also includes midtown plaza located not far from high view. Disgrace you know. I think they have the worth all to address some of these concerns and you know all too often. People like to make excuses in mckeesport. That's mckeesport mayor. Michael sharp co he and other elected officials are now calling on the bank to quickly make improvements. Pnc says it aims to preserve these kinds of apartments and ensure their long term affordability for residents. The bank says if they were bought by other investors those units would be at risk of becoming market rate housing that could lead to tenants being displaced todd. Crow is an executive vice president and manager of tax credit solutions for pnc bank or motivation and acquiring each of these properties was to make sure that they would remain available for the tenants that live there and assistance contract would be renewed. Pnc also says it's a long term goal is to improve the properties using low income housing tax credits. Crow acknowledged some of the problems residents face. It high few doe. He says some issues were due to disruptions caused by the pandemic but residents say things went downhill long before cove it. They were twenty twenty december. Twenty twenty i think duster resident. Tanya brown has stacks of letters from the allegheny county health department documenting complaints about conditions at high few over the years and there's data tobacco her concerns last year. Forty two percent of all the housing-related violations logged by the county health department in mckeesport were from the high view in midtown complexes over the three years prior violations from the complexes had only accounted for around ten percent of the city's violations public data also reveals that in the first two years after. Pnc took over nine one. One calls increased by forty six percent compared to the two years prior some experts. Say these are symptoms of broader problems. The pittsburgh regions shortage of affordable units means tenants have to put up with conditions. They might not tolerate otherwise others. Note that while the us department of housing and urban development inspects properties. It doesn't regularly contact local code enforcement officials since investigation. Pnc has pledged to take immediate action to ensure that tenant concerns are addressed calling the conditions quote unacceptable. The company that manages the buildings for pnc did not respond to requests for comment. Pnc officials recently met with members of the high few gardens tenant council those discussions are expected to continue in the meantime tenant union president. Tanya brown says shall keep pushing to make high view a better place for the families who live there. I'm not here just for myself. I'm here for everybody else to. I'm not just in this for myself. You know for here are now. I'm marie c. In pittsburgh and we wanna give credit to rich lord public source who reported this story with case..

pnc mckeesport Heidi gardens Dacia hooper radia community justice project tanya brown pittsburgh mckeesport urban holdings to l dacia hooper barbara brown Michael sharp Tanya brown Crow lincoln somerset columbia allegheny county health depart
"biontech" Discussed on Here & Now

Here & Now

05:29 min | 1 year ago

"biontech" Discussed on Here & Now

"And what all was at play in some of these communities. We've also seen that You know weather forecasters are also discussing how they communicate. Risks to residents. So yeah. we're we're still in an unfolding situation here. I think there's going to be a lot a lot of Lots to look into tony. Gonzales is news editor and wpn. In nashville tony. Thank you very much for your reporting appreciate it Some are in the gulf states. That's florida alabama. Mississippi louisiana and texas draws a lot of tourists and this year's numbers do not disappoint but that influx of people into a region with relatively low rates vaccination against cova nineteen is fueling a deadly spike in infections. Transmission rates in many counties are more than twice the national average and hospitals are buckling under the strain. The singing river health system is among them. They operate three hospitals along. Mississippi's gulf coast. Dr randy roth is chief medical officer there. Dr roth welcome and can you give us an idea of what it is like inside your hospitals right now. Sure it's probably the worst situation that i've dealt with twenty two years of practicing medicine. We have no beds. We have no. Icu beds this morning. As i drove in at six thing in we have over twenty two patients that are waiting in our emergency room to be placed in a true hospital bed and what that means is people are getting cared for by great. Er nurses but that's not what they're supposed to be doing. They're supposed to be taking care of emergency room patients so when you hear that term boarding. They're sitting in the er waiting to go to. The icu are waiting to go to step down. Unit and those bedroom being occupied by kobe patients who this wave or just living longer. It's a younger subset of patients and we have a hard time getting them out of the hospital. And that's slow the process down the other thing you hear about it just nursing shortages. We have issued beds. We can't open because we can't staff them. The morale is strong but When you have mandated overtime and you're walking into the and you have eighteen patients that have been there overnight. The next day it's tough and lastly it's just the isolation of the disease so someone with covert may stay in the hospital twenty one days and only contact. They have with their family is via cellphone or facetime. It wears you thin and we are frustrated. But we're working hard to hopefully get past this wave. We're hearing from not just healthcare professionals but patients as well one family posted a video of their child who has cancer and had to wait in the parking lot for hours because he couldn't get into get treated what are you seeing. As as sort of the trickle down effects of this kind of overflow the biggest problem i have with this is are we prepared for something on top of cohen. If we get a category four storm can we take care of the three or four hundred people that immediate care if we have a bus that hits a train them. I need to intubate in put fourteen teenagers on the ventilator that clearly can survive. Do we have capacity to do that. People are putting off elective surgeries That are time sensitive. Because we can't do them. Is that colon cancer or breast cancer. Going to spread in the interim time that we wait to do that. I have to cancel over fifteen coronary rebroadcast graphs or bypass surgeries. Because we can't bed. These patients we'll have nurses to take care of in the icu and these are patients. That are clearly fixable incurable. But they're waiting at home for the call. Say we have a bed for you award about that constantly. And we've heard some tragic stories coming out of your hospital. There was a husband and wife In their forties both unvaccinated. They died within days of each other and one of your own nurses was unvaccinated. Forty eight years old also died. What is your hospital. Need most at this moment in our biggest need right now would probably be bedside med surge issue nurses that we could staff and open up. More beds to unclog are -mergency department. That would be our biggest help in terms of supplies. We're close on ventilators. But i think we have that covered the nursing shortage than anyone else terms a boots on the ground. They can help us do vaccinations. Or the monoclonal antibody infusions because when we take and we start given i-i've regeneration we need nurses to do that so we're taking nurses that could be at the bedside to administer the antibodies. The last thing is the educate people about being vaccinated. I know pfizer announced that to got. Fda approved today. Maybe that'll help our numbers but The vaccine's been well studied and it's very frustrating that people will not be vaccinated but they will take ivermectin or all these over the counter things that have been started on the internet very frustrating for the front line staff to have to deal with that a lot of these or affordable cases ninety five percent of our patients in the hospital with kobe today. You're back sedated. And the numbers don't lie. That's where we stand dr randy roth. Chief medical officer at singing river health system in gulfport mississippi operates three hospitals. They're all at capacity with code nineteen patients. Dr roth i really appreciate it. Thank you so much and good luck. Thank you so lost. In pennsylvania. residents of to affordable housing complexes are demanding. Better living conditions reported health code violations in nine one.

Dr roth Dr randy roth Mississippi tony gulf states Gonzales gulf coast nashville louisiana kobe alabama florida texas cohen colon cancer breast cancer cancer pfizer dr randy roth
"biontech" Discussed on Here & Now

Here & Now

03:09 min | 1 year ago

"biontech" Discussed on Here & Now

"Then more than that too. That's how storm moved so this was more rain in a shorter time than even the the catastrophic flooding in twenty ten so people here first responders they just know this is beyond anything they've ever seen and then that town of waverley the hardest hit. It turned their creek truly into a massive river for it for a while. What we know about the people who died while. There's still a lot a lot to learn this much loss of life You know we talked to a friend of a man who ran a pawnshop in waverly He was grieving his loss. Another victim was the ranch foreman at singer. Loretta lynn's ranch. That's sort of in a historic area called hurricane mills. We also know that families lost children including twin infants who were were swept away from their parents as they were trying to find safety We're several days on now at this point. What does the search effort look like for the people who are missing. What's involved with that. Yeah i think it's mostly a recovery effort at this point so you know. Part of it is what you might expect. First responders are going house to house or car by car. And when i say that i mean there's cars are turned over. Sort of piled up leaning against poles and homes. They're marking homes and cars with with a blue spray paint x. Once it's been checked then there's this other challenge. Communications have been really rough in that area. They went down. So it's been tough to know who is still missing. Some of the local authorities have gone onto facebook to post. You know literally lists of names of people who are missing or suspected missing then residents are going on there to either get information or to make posts about people that they they know to be safe course once you see that on social media than the authorities are trying to confirm that info either with a phone call and there's also a reunification center at a local high school so you know they're searching physically and then they're also trying to use kind of word of mouth to figure out a who still needs to be found have the floodwaters fully receded yet. And i ask that because you were describing some of the damage. I'm wondering if there is a full picture. Yet of how much has been lost. The waters have largely receded. I mean this was flash flooding situation. So you know. I think as i saw information that some of the rivers had sort of crested. And we're returning down to their to their normal toward their normal levels But yeah there's there is still a lot of damage still to assess for sure right well We know that right now. People are clearly focused on on the recovery grieving over the losses from this storm. But is there talk yet of longer term preparations so that something like this doesn't happen again while yeah i mean. I think that is on minds. Of course the immediate crisis is still sort of unfolding here With the number of missing missing people. I think will take more time to really understand this specific really intense rainfall and what all was at play in some of these communities. We've also seen that You know weather forecasters are also discussing how they communicate. Risks.

hurricane mills waverley Loretta lynn waverly facebook
"biontech" Discussed on Here & Now

Here & Now

06:21 min | 1 year ago

"biontech" Discussed on Here & Now

"From npr and wbz are piero doubt. I'm celeste headley. It's here and now the us food and drug administration has given its full approval to a covert nineteen vaccine for the first time. The fda said today that the two does visor by on tech vaccine quote meets the high standards for safety effectiveness and manufacturing quality to be approved for people sixteen and older it and other vaccines remain available to people as young as twelve years old under emergency use authorization granted in december. Let's bring in dr joshua scharfstein. He's vice dean for public health. Practice and community engagement at the johns hopkins bloomberg school of public health. Dr thank you so much for joining us. Thank you for having me on a basic level. What does it mean to get a full approval from the fda. Well it means that the food and drug administration scientists and expert regulators have poured over a lot of information that the company has submitted about the safety the effectiveness and the manufacturing of a product and found that the benefits exceed the risks. And it deserves to be on the market. As i mentioned this means it's approved for people sixteen and older. What does this mean for use in younger children. There are additional studies. That are still going on for kids under twelve and what. Those studies show will really determine what happens to the vaccine for that population. So according to a kaiser family foundation poll in june thirty one percent unvaccinated. people said. At that time they'd be more likely to get a covert nineteen vaccine Once one of them received full approval from the fda how do you think this approval might affect our national efforts to get people vaccinated. I think it will help. I think that people who were wondering who had been reading while this is just for an emergency. This is based on a review. Just a couple of months of safety data will be able to feel more confident that the vaccine has held up after millions of people have been vaccinated. And just an incredible record of what's happened so far. And what about vaccine. Mandates is it easier to mandate that people get shot if if it's gotten fda approval. Well i think it is Not necessarily for legal reasons. But just because i think people will be more comfortable asking requiring that their employees for example who are dealing with the public or who are working very close to one another take a vaccine that the fda has thoroughly reviewed companies healthcare organizations for example. Have done that already. And i think that that made sense based on just the berries strong track record that the vaccine had under emergency use authorization but now that extra step has been taken. I think more businesses will do that. Because they want to protect booth their workers and the public that their workers may be interacting with so maderna's version of the vaccine was authorized for emergency. Use just a week after pfizer's was is it reasonable to expect. Madonna might also get fda review and approval soon. I think that's that's reasonable. The vaccines are so similar. It's really important to appreciate that. Many many millions of people have been back standard with these two vaccines and the track record has been very strong so i i have no doubt that. At some point the Madonna vaccine will be licenses. Wow so that's the second time you have made a statement of that type of which is something like this has been used. Millions of people have taken it. The records in evidence shows that it's safe. How do you think this conversation is going. I mean for people. Even i who cover events like this I don't fully understand everything that goes into something like a vaccine development and fda approval. How do you think this conversation is going with people who still feel nervous about it. Well i think there's a couple of things to say both the emergency use authorization and the license note that there are side effects from the vaccine because their side effects from everything that is used in medicine in particular. The license application talks about the rare chance of heart inflammation which it looks like resolves in almost all the cases pretty rapidly but the fda has asked the company to do longer term studies. So i think it's going to be important for people to realize that this is a judgment call but the judgment call isn't a very hard one because the benefits of avoiding covert action and cove. Infection can cause serious problems with the heart. Our foreign access of the risks of the vaccine. I think that while the licensor decision will make that conversation easier for some people. There will be others who are still reluctant. There's a natural reluctance to take on any risk. When you're worried about just the chance that you're making a decision that could cause a problem and we don't necessarily think about the risks that you know we're not seeing directly like the risk of getting sick with the virus so i think they'll have to be still a lot of conversations a lot of chances for people to get their questions answered before we see a lot. More people getting backs needed. Dr jesuit scharfstein is vice dean for public health practice and community engagement at johns hopkins bloomberg school of public health. Dr scharfstein thank you so much. Thanks again well. The northeast was spared over the weekend from some of the worst impacts of tropical storm. Honoree a separate more catastrophic situation was playing out in tennessee on saturday. A series of storms dumped more than seventeen inches of rain in just twenty four hours. In parts of humphreys county west of nashville flash floods followed. At least twenty. Two people are dead and today many are still missing. Humphreys county sheriff. Chris davis spoke this morning. With the cbs. Affiliate in nashville. I want you to think of it. How much in-in-in that we're talking about. In the shopping center in wired really the dollar general store we had people employees that were working in there and they were trying to do things they were in. You know in knee deep water. The next thing make no water bus through the.

fda wbz celeste headley dr joshua scharfstein johns hopkins bloomberg school piero maderna kaiser family foundation npr heart inflammation pfizer Madonna Dr jesuit scharfstein Dr scharfstein humphreys county Humphreys county nashville tennessee
FDA Grants Full Approval to Pfizer-BioNTech Vaccine, Clearing Path to More Mandates

Mike Gallagher Podcast

01:34 min | 1 year ago

FDA Grants Full Approval to Pfizer-BioNTech Vaccine, Clearing Path to More Mandates

"Finally the fda has given full approval to one of the vaccinations against cova nineteen or four cova. Nineteen it's the pfizer cova nineteen vaccine federal regulators moments ago as expected full approval. The fda approved pfizer's to dose shot. And of course immediately. The analysis is this is a step that could lead to more vaccine. Mandates approval for pfizer's to dose vaccine was originally scheduled for labor day but was moved up due to a spike in cases. According to the new york times. So i'll watch a few weeks. We've got a spike. Let's do it now and would lead one to wonder. Why did you do it. Six months ago. How long does it take to get regulators to give fda approval to a vaccine. And what about those of us. Who got madonna or johnson and johnson. But maybe this will be what the smart kids want. Vaccine mandates more vaccinations. Maybe that will work because you do realize the dirty little secret is nothing's work. Nothing's working all over. The world. countries are struggling still with cove it

FDA Pfizer The New York Times Johnson Madonna
"biontech" Discussed on TIME's Top Stories

TIME's Top Stories

02:38 min | 1 year ago

"biontech" Discussed on TIME's Top Stories

"Meanwhile the more contagious delta variant. The virus is spreading rapidly among the unvaccinated population. The spike in covert nineteen cases in states that have low. Vaccination rates has threatened to claw the us back into the worst of the pandemic and it creates a looming political liability for biden on august. Third biden gave a sober speech from the east room of the white house. Saying the country's best line of defense against the virus is the vaccine. it's as simple as that period. The vaccine he said but as biden attempts to mount more aggressive vaccination efforts to stave off the spread of the highly transmissible delta variant the fact that the fda has yet to fully approve any of the vaccines is threatening to slow progress about thirty percent of unvaccinated. People say they would be more likely to get a shot with full. Fda approval according to recent polls from the kaiser family foundation while the pollsters warn that may be a proxy for more general concerns. Some doctors and public health experts in.

biden white house Fda us kaiser family foundation
Darren Elias: How the Online Game Has Changed

Chasing Poker Greatness

02:28 min | 1 year ago

Darren Elias: How the Online Game Has Changed

"Mr elias. Welcome back to the show sir. How you doing good good. Thanks happy to be ed's it's my pleasure. It's my pleasure. If i remember correctly in the last time we spoke. You told the listener. Did they could find you at the regatta. And i gotta say some things have happened since then so tell me what's been going on in your world over the last year or last year. I've been playing a lot of online poker. I'd say i've kind of shifted when We coded hit in there. Were no live tournaments. I kind of have this choice. Am i gonna stay at home and play that much poker. Become complacent or Kind of make something happened in Compete online in these in these bigger games. And get back to playing online tournaments. Which is which is what. I've been doing the last year or so and how how's that been playing in the online world. Pretty good that. The game definitely changed a bit since since when i came up online which was thousand. Eight two thousand eleven inches seem so long ago that the binds are so much bigger level plays so much higher. You really have to try to bring your best everyday compete or or you're gonna get crushed because these guys were good on the The global networks the g. Jeez the party poker and the by Of the high stakes just changed so much. Where when i was coming up a big sunday might play five thousand ten thousand in biontech and now some of these sundays. I'm finding. I'm in for one hundred and fifty two hundred thousand playing the regular schedule on digi a party. It's it's gotten so big you had ape styles on before the pandemic and he was talking to me about like the regular twenty five ks on gee-gee and like racking up like a million wins having selection and then taking all of himself and going on a downer and like being stuck for the experience over this it was like a month and a half of like winning a million losing a million pretty crazy. Yeah i was looking at the stats. Wherever i think i. I've my earnings which isn't prophet. Of course probably one more In the last six months than i have in my whole online career just because of the by in the nature these tournaments with re entry to somebody's twenty-five gizeh five six hours of re entry in reenter with ten blinds. So it's it's pretty

Mr Elias ED
The Latest: Pfizer-BioNTech pledge 2B doses to poor nations

AP News Radio

00:45 sec | 1 year ago

The Latest: Pfizer-BioNTech pledge 2B doses to poor nations

"Have we turned the corner on the corona virus coronavirus infections are down to their lowest levels since last June and deaths are down to to a level not seen since July the percentage of Americans were fully vaccinated thirty eight percent about forty eight percent of gotten at least one Kovic shot according to Bloomberg's cove it tracker now the question many are asking if you've been vaccinated will you need a booster shot in the fall the nation's top infectious disease expert Dr Anthony Fauci says maybe they don't know yet he tells CBS this morning that scientists are still tracking data on the virus possible variants he's also reminding those who haven't been fully vaccinated to keep the mask on I read a folate

Kovic Dr Anthony Fauci Bloomberg CBS
EU Signs New Deal With Pfizer-BioNTech, Hungary Opts Out

AP News Radio

00:42 sec | 1 year ago

EU Signs New Deal With Pfizer-BioNTech, Hungary Opts Out

"The European Union has signed a new deal with fines up by on tech but one block country hungry is opting out the bloc's executive arm this finalized a flood faxing contract with FISA biotech food twenty twenty three for an additional one point eight billion doses of that could be nineteen shots to share between the blocks countries except for hungry the European Commission says the contract which is agreed on behalf of all twenty seven EU countries early this month will allow the bond of nine hundred million doses of the current Schultz I'm over serum adopted to the viruses veterans with an option to purchase an extra nine hundred million of them I'm Charles de Ledesma

EU European Commission Schultz Charles De Ledesma
Pfzier and BioNTech to Donate Vaccines for Olympic Athletes

AP News Radio

00:38 sec | 1 year ago

Pfzier and BioNTech to Donate Vaccines for Olympic Athletes

"The international Olympic committee says delivery of doses is set to begin this month to give delegation this time to be fully vaccinated with a second shop before arriving for the games which open on July twenty three the new files offer gives greater coverage will white head of Tokyo with most countries yet to authorize emergency use of Chinese vaccines in March the IOC had agreed with officials in China to buy and distribute its vaccines ahead of the Tokyo games and then the Winter Games IOC president Thomas Bach says he hopes athletes will lead by example and accept the vaccine where and when possible I'm Charles that's my

International Olympic Committe Tokyo Thomas Bach China Charles
EU: 100 Million More Pfizer/BioNTech Doses to Come

AP News Radio

00:52 sec | 1 year ago

EU: 100 Million More Pfizer/BioNTech Doses to Come

"The pharmaceutical company by on tech and its US partner finds a sense they will provide one hundred million more doses of the coronavirus vaccine to the European union this year the two companies say the twenty seven nations executive commission has exercised an option to purchase the additional doses bringing the total number of shots set of delivery to the E. U. in twenty twenty one to six hundred million the announcement offers a much needed boost to the E. U.'s sluggish and much criticized vaccine rollout biotech's chief business officer Shawn Merritt says deliveries of the company's M. RNA based vaccines this year will cover two thirds of the E. U. population the block has so far administered about one hundred five million shots to its population of some four hundred fifty million people I'm Charles the last month

Twenty Seven Nations Executive E. U. Shawn Merritt United States Charles
The Pfizer-BioNTech Vaccine Is Said to Be Powerfully Protective in Adolescents

Ray Appleton

00:33 sec | 1 year ago

The Pfizer-BioNTech Vaccine Is Said to Be Powerfully Protective in Adolescents

"In Children ages. 12 to 15. The news comes as covert 19 cases are on the rise again. Health officials with the White House covert task force say they're worried about another surge in the U. S. Dr. Anthony Fauci, We have seen now immune protection. Against Cove in 19 variants when individuals of vaccinated against the wild type strain on two mechanisms, the anybody response that has a spillover effect. As well as the cross reactivity. Today, Fresno Kings and Madeira counties

S. Dr. Anthony Fauci Against Cove White House U. Fresno Kings Madeira
Pfizer and BioNTech  trial shows Vaccine is safe

NPR News Now

00:17 sec | 1 year ago

Pfizer and BioNTech trial shows Vaccine is safe

"Biontech say a small clinical trial. They're tracking shows that they're covid. Nineteen vaccine is safe and strongly effective in children. As young as twelve. most co- vaccines are for adults. Although pfizer's shot can be used in people aged sixteen and seventeen stocks

Pfizer
Johnson & Johnson one-shot COVID vaccine rolls out in the U.S.

Democracy Now! Audio

00:48 sec | 1 year ago

Johnson & Johnson one-shot COVID vaccine rolls out in the U.S.

"And johnson's covid nineteen vaccine is starting to roll out across the united states after it received final approval of the centers for disease control unlike the two other approved vaccines in the us. Madeira and pfizer. Biontech johnson and johnson requires one shot and does not need to be stored in the freezer. This comes as health. Experts warn the recent decline in cases is slowing down as more states. Move to relax restrictions this is. Cdc director dr rachelle landscape. We may be done the virus but clearly the virus is not on with us. We cannot get comfortable or give in to a false sense of security that the worst of the pandemic is behind us not now not when mass vaccination that is so very

Biontech Johnson Johnson CDC Madeira Dr Rachelle United States Pfizer
Germany's rollout of Coronavirus vaccine is very slow

Monocle 24: The Briefing

00:39 sec | 1 year ago

Germany's rollout of Coronavirus vaccine is very slow

"Modern times. Germany has basked in arguably earth's most flattering national stereotype that of a calm practical and orderly nation which just get stuff done without making thing that that reputation is being tested. If not outright joined by germany's bewilderingly. Sluggish rolled out of covid nineteen. Vaccines a sloth. Which seems all the stranger when it is recalled at one of the first vaccine which worked was developed in part by biontech a german company while germany's vaccine deployment is about power with the eu as a whole it is noticeable stretch behind for example that of the united kingdom

Germany EU United Kingdom
"biontech" Discussed on TIME's Top Stories

TIME's Top Stories

03:53 min | 1 year ago

"biontech" Discussed on TIME's Top Stories

"Pfizer and bio. Intech say. They've won permission wednesday for emergency use of their covid nineteen vaccine in britain. The world's first corona virus shot that's backed by rigorous science and a major step toward eventually ending the pandemic. the move makes britain one of the first countries to begin vaccinating. Its population as it tries to curb. Europe's deadliest covid nineteen outbreak. Other countries aren't far behind the us. And the european union also are vetting. The pfizer shot along with a similar vaccine made by competitor. Moderna inc pfizer said it would immediately begin shipping limited supplies to the uk and has been gearing up for even wider distribution if given a similar nod by the us food and drug administration. A decision expected as early as next week but doses everywhere are scarce and initial. Supplies will be rationed until more is manufactured in the first several months of next year visor. Co albert birla called the uk decision. A moment we are focusing on moving with the same level of urgency to safely supply. A high quality vaccine around the world bore said in a statement while the uk has altered enough pfizer vaccine for twenty million people. It's not clear. How many will arrive. By year's end. And adding to the distribution challenges is that it must be stored at ultra cold temperatures two doses. Three weeks apart are required for protection first in line. The uk government says our frontline healthcare workers and nursing home residents followed by older adults british regulators. Also were considering. Another shot made by astrazeneca and oxford university but prime minister. Boris johnson has warned. We must i navigate a hard winter of restrictions to try to curb the virus until there's enough vaccine to go around. Every country has different rules determining when an experimental vaccine is safe and effective enough to use intense political pressure to be the first to roll out a rigorously. Scientifically tested shot colored the race in the us and britain even as researchers pledged to cut no corners and contrast china and russia have offered different vaccinations to their citizens ahead of late. Stage testing the shots made by us based pfizer and its german partner bio intech were tested in tens of thousands of people and while that study isn't complete early results suggest. The vaccine is ninety five percent effective at preventing mild to severe covid nineteen disease the company's told regulators that of the first one hundred seventy infections detected in study volunteers. Only eight were among people who'd received the actual vaccine and the rest had gotten a dummy shot. This is an extraordinarily strong protection. Dr uber sahin. A bio intex. Ceo recently told the associated press. The companies are reported. No serious side effects. Although vaccine recipients may experience temporary pain and flu-like reactions immediately after injections but experts caution that a vaccine cleared for emergency use is still experimental and the final testing must be completed still to be determined is whether the pfizer bio tech shots protect against people spreading the coronavirus without showing symptoms. Another question is how long protection lasts. The vaccine also has been tested in only a small number of children none younger than twelve. And there's no information on its effects in pregnant women.

pfizer Moderna inc britain us food and drug administratio uk albert birla lauren european union bio intech Boris johnson astrazeneca us Europe oxford university Dr uber sahin russia china the associated press